Literature DB >> 35585382

Ethacrynic acid and cinnamic acid combination exhibits selective anticancer effects on K562 chronic myeloid leukemia cells.

Münevver Yenigül1, İsmail Akçok2, Emel Başak Gencer Akçok3.   

Abstract

BACKGROUND: Despite the recent advances in chemotherapy, the outcomes and the success of these treatments still remain insufficient. Novel combination treatments and treatment strategies need to be developed in order to achieve more effective treatment. This study was designed to investigate the combined effect of ethacrynic acid and cinnamic acid on cancer cell lines.
METHODS: The anti-proliferative effect of ethacrynic acid and cinnamic acid was investigated by MTT cell viability assay in three different cancer cell lines. Combination indexes were calculated using CompuSyn software. Apoptosis was assessed by flow cytometric Annexin V-FITC/PI double-staining. The effect of the inhibitors on cell cycle distribution was measured by propidium iodide staining.
RESULTS: The combination treatment of ethacrynic acid and cinnamic acid decreased cell proliferation significantly, by 63%, 75% and 70% for K562, HepG2 and TFK-1 cells, respectively. A 5.5-fold increase in the apoptotic cell population was observed after combination treatment of K562 cells. The population of apoptotic cells increased by 9.3 and 0.4% in HepG2 and TFK-1 cells, respectively. Furthermore, cell cycle analysis shows significant cell cycle arrest in S and G2/M phase for K562 cells and non-significant accumulation in G0/G1 phase for TFK-1 and HepG2 cells.
CONCLUSIONS: Although there is a need for further investigation, our results suggest that the inhibitors used in this study cause a decrease in cellular proliferation, induce apoptosis and cause cell cycle arrest.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Apoptosis; Cancer; Cell cycle; Cinnamic acid; Combination therapy; Ethacrynic acid

Mesh:

Substances:

Year:  2022        PMID: 35585382     DOI: 10.1007/s11033-022-07560-5

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.742


  35 in total

1.  Antifungal activity of cinnamic acid and benzoic acid esters against Candida albicans strains.

Authors:  Tamires C Lima; Alana R Ferreira; Daniele F Silva; Edeltrudes O Lima; Damião P de Sousa
Journal:  Nat Prod Res       Date:  2017-04-20       Impact factor: 2.861

Review 2.  Cinnamic acid derivatives as anticancer agents-a review.

Authors:  P De; M Baltas; F Bedos-Belval
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

3.  Novel oxadiazole analogues derived from ethacrynic acid: design, synthesis, and structure-activity relationships in inhibiting the activity of glutathione S-transferase P1-1 and cancer cell proliferation.

Authors:  Xinmei Yang; Guyue Liu; Hongcai Li; Yun Zhang; Dandan Song; Chunmin Li; Rui Wang; Bo Liu; Wen Liang; Yongkui Jing; Guisen Zhao
Journal:  J Med Chem       Date:  2010-02-11       Impact factor: 7.446

4.  Characterization of cell death induced by ethacrynic acid in a human colon cancer cell line DLD-1 and suppression by N-acetyl-L-cysteine.

Authors:  Shu Aizawa; Keizou Ookawa; Toshihiro Kudo; Junpei Asano; Makoto Hayakari; Shigeki Tsuchida
Journal:  Cancer Sci       Date:  2003-10       Impact factor: 6.716

Review 5.  The role of glutathione-S-transferase in anti-cancer drug resistance.

Authors:  Danyelle M Townsend; Kenneth D Tew
Journal:  Oncogene       Date:  2003-10-20       Impact factor: 9.867

6.  Ethacrynic acid can be effective for refractory congestive heart failure and ascites.

Authors:  Joseph M Alisky; Thomas F Tuttle
Journal:  South Med J       Date:  2003-11       Impact factor: 0.954

7.  Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1-1 inhibition.

Authors:  Rui Wang; Chunmin Li; Dandan Song; Guisen Zhao; Linxiang Zhao; Yongkui Jing
Journal:  Cancer Res       Date:  2007-08-15       Impact factor: 12.701

Review 8.  Glutathione transferases: substrates, inihibitors and pro-drugs in cancer and neurodegenerative diseases.

Authors:  Nerino Allocati; Michele Masulli; Carmine Di Ilio; Luca Federici
Journal:  Oncogenesis       Date:  2018-01-24       Impact factor: 7.485

Review 9.  Natural cinnamic acids, synthetic derivatives and hybrids with antimicrobial activity.

Authors:  Juan David Guzman
Journal:  Molecules       Date:  2014-11-25       Impact factor: 4.411

10.  Ethacrynic acid exhibits selective toxicity to chronic lymphocytic leukemia cells by inhibition of the Wnt/beta-catenin pathway.

Authors:  Desheng Lu; Jerry X Liu; Tomoyuki Endo; Haowen Zhou; Shiyin Yao; Karl Willert; Ingo G H Schmidt-Wolf; Thomas J Kipps; Dennis A Carson
Journal:  PLoS One       Date:  2009-12-14       Impact factor: 3.240

View more
  1 in total

1.  Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia.

Authors:  Liling Jiang; Qingyan He; Xin Chen; Aochu Liu; Wa Ding; Haichuan Zhang; Xinmei Chen; Huan Zhou; Yi Meng; Bingyuan Liu; Guanjie Peng; Chunyan Wang; Jinbao Liu; Xianping Shi
Journal:  Clin Transl Med       Date:  2022-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.